News

Trial Innovation Network (TIN) collaboration webinar Feb 1st, 2021 - Overview and update on the status of N3C, followed by presentations from 3 of the N3C Domain Teams on how they can inform clinical trial protocol development.

NeuroCOVID creates and maintains a national resource for documenting and studying neurological complications of coronavirus disease (COVID-19), the illness caused by infection with the SARS-CoV-2 novel coronavirus.

This multi-center dataset supports robust evidence-based development of predictive and diagnostic tools and informs critical care and policy.

A powerful tool for researchers! Having access to a centralized enclave of this magnitude allows research teams to study, probe and answer clinically important questions about COVID-19 that they could not have answered previously.

With the AMIA 2020 fall meeting behind us, you still have the opportunity to continue your informatics professional development and learning. We have packaged the most content ever obtained from an AMIA Annual Symposium.

In this new video series, hear from researchers at NIH and beyond on how Translational Science is speeding the identification and development of diagnostic and treatment approaches.